Randomized controlled trial2025Open access

Benefits of Krill Oil Supplementation During Alternate-Day Fasting in Adults With Overweight and Obesity: A Randomized Trial

Alblaji M, Gray SR, Almesbehi T, Morrison DJ, Malkova D

Obesity (Silver Spring, Md.) · 2 citations

How it was studied

Design
Randomized controlled trial (indexed by PubMed)
Studied in
People
Main outcome
Health markers and function

Who paid for it

Funding
Independent funding
University or hospital
Qassim University
Government
Government of Saudi Arabia

Based on 2 listed funder(s) and full-text disclosure statement.

Publication

Published
2025-07-16 · Obesity (Silver Spring) · vol. 33 · issue 9 · pp. 1694–1703
Publisher
Wiley
Cited
3 citations · more than 84% of similar papers · 1.6× the field average
References
52 works
Access
Open access (hybrid journal) · CC-BY
Research areas
Dietary Effects on Health · Muscle metabolism and nutrition · Fatty Acid Research and Health
Keywords
Medicine, Overweight, Placebo, Animal science, Krill, Obesity, Randomized controlled trial, Internal medicine, Endocrinology, Biology
MeSH
animals, humans, euphausiacea, obesity, weight loss, xanthophylls, docosahexaenoic acids, eicosapentaenoic acid, body mass index, hand strength, fasting, double-blind method, body composition, dietary supplements, adult, middle aged, female, male, overweight

5 authors

From SA, GB, LT

  • Mansour AlblajiQassim University; University of Glasgow
  • Stuart Robert GrayLithuanian Sports University; University of Glasgow
  • Taibah AlmesbehiUniversity of Glasgow
  • Douglas J. MorrisonScottish Universities Environmental Research Centre
  • Dalia Malkova · correspondingUniversity of Glasgow

Abstract

Objective

To investigate the effect of krill oil (KO) supplementation during alternate-day fasting (ADF) on body composition and muscle function in healthy adults with overweight.

Methods

In a randomized trial, during the 8-week ADF, participants consumed four capsules per day containing krill oil (KO group) or vegetable oil (placebo group). Each capsule of KO contained 191 mg EPA, 94 mg DHA, 78 mg choline, and 100 mcg astaxanthin. Body mass, fat-free mass (FFM), and handgrip strength (HGS) were measured before and after the intervention. Data were analyzed using ANOVA.

Results

The study was completed by 41 (25 women and 16 men) participants (age: 39 ± 10 years, BMI: 31.1 ± 4.2 kg/m2). Body weight reduction was not different (p > 0.05) between groups (KO, -4.6 ± 1.4 kg; Placebo, -4.5 ± 1.9 kg). The KO group had no change (p > 0.05) in FFM (-0.2 ± 0.9 kg) or HGS (-0.2 ± 0.5 kg). The placebo group experienced a reduction (p < 0.05) in FFM (-1.2 ± 2.0 kg) and HGS (-0.9 ± 0.7 kg). Changes in FFM and HGS were different (p < 0.05) between groups.

Conclusions

KO supplementation during body weight loss attenuates the decline in FFM and muscle strength.

Trial registration

ClinicalTrials.gov Identifier (NCT06001632).

Abstract via Europe PMC. Copyright remains with the authors or publisher (CC BY).

Community trust

Loading…

How much do you trust this study's findings?

0 · not at all10 · completely

Comments

Sign in to rate, comment on or flag this study.Sign in

Something wrong here?

Flag this study if its information, labels or funding look wrong. An editor reviews every flag.

Sign in to rate, comment on or flag this study.Sign in

Educational information about published research. Not medical advice, and not a recommendation to start or stop anything.